Dobutamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company · Available
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 11/06/2017
- Package NDC
- 0409-0151-10
- Generic name
- Dobutamine Hydrochloride Injection
- Contact info
- 844-646-4398
- Availability
- Available
- Update date
- 09/22/2026
- Dosage form
- Injection
- Presentation
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10)
- Company name
- Hospira, Inc., a Pfizer Company
- Status
- Current
- Therapeutic category
- Cardiovascular, Pediatric, Renal
- Harmonized identifiers (openFDA)
- Application number
- NDA020201
- Brand name
- DOBUTAMINE IN DEXTROSE
- Generic name
- DOBUTAMINE IN DEXTROSE
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-0151, 0409-2347, 0409-2346, 0409-3724, 0409-0025, 0409-1100
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- DOBUTAMINE HYDROCHLORIDE
- RxCUI
- 309985, 309986, 309987
- SPL ID
- b02881e1-8e01-4bff-b82e-9d9ec41c7396
- SPL set ID
- 9943a961-3b50-4847-8a84-d8414ce38daa
- Package NDC
- 0409-2347-31, 0409-2347-32, 0409-2346-31, 0409-2346-32, 0409-3724-11, 0409-3724-32, 0409-0025-01, 0409-0025-10, 0409-0151-01, 0409-0151-10, 0409-1100-01, 0409-1100-10
- UNII
- 0WR771DJXV